ACTRN12610000055000进行中（未招募）未知
Response Post Tyrosine Kinase Inhibitor: Assesment of sensitivity and therapeutic response to next-line therapy in Chronic Myeloid Leukaemia (CML).
Australasian Leukaemia and Lymphoma Group (ALLG)0 个研究点目标入组 1,000 人开始时间: 2010年1月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- All
入选标准
- •Patients of any age
- •Currently recieving Tyrosine Kinase Inhibitor(TKI)
- •Patients with Philadelphia Positive or Breakpoint Cluster Region (BCR) V-abl Abelson murine leukaemia viral oncogene homolog1 (ABL) confirmed CML.
- •Patients in any phase of CML including those with relapsed CML following allogeneic stem cell transplantation
- •Patients who can provide written informed consent. Minors must have parental/legal guardian consent and assent where required
排除标准
- •If in the investigator's opinion the patient is unlikely candidate for follow-up information due to unavailability.
- •Previous enrolment to the same registry.
研究者
相似试验
进行中（未招募）
不适用
Factors affecting tyrosine kinase inhibitors response in chronic myeloid leukemia patientsDespite the excellent efficacy obtained for the treatment of CML,a significant proportion of patients develop resistance to tyrosine kinase inhibitors.TCTR20180703001/A100
进行中（未招募）
不适用
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)MedDRA version: 14.1Level: LLTClassification code 10000844Term: Acute lymphoblastic leukaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10034877Term: Philadelphia chromosome positiveSystem Organ Class: 10022891 - InvestigationsEUCTR2010-022946-25-Outside-EU/EEAChildren's Oncology Group195
已完成
不适用
Safety and efficacy of tyrosine kinase inhibitors for the treatment of severe and progressive pulmonary hypertensiopulmonary hypertensionJPRN-UMIN000015696Hokkaido University Hospital, Internal medicine I5
尚未招募
Unknown
A Clinical Study on Drug Resistance in CML(Chronic Myeloid Leukemia)CTRI/2024/08/072505Indian Council Of Medical Research
已完成
不适用
The Effect of Tyrosine Kinase Inhibitor on Thyroid Function in Patients with Chronic Myeloid LeukemiaChronic Myeloid LeukemiaJPRN-UMIN000015824Keio University School of Medicine100